A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic triple-negative breast cancer
- Bardia, A.
- Hurvitz, S.A.
- Rugo, H.S.
- Brufsky, A.
- Cortes, J.
- Loibl, S.
- Piccart, M.
- Cowden, J.
- Spears, P.
- Carey, L.A.
ISSN: 1744-8301, 1479-6694
Year of publication: 2021
Volume: 17
Issue: 30
Pages: 3911-3924
Type: Article